Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.29557 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.28642 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.30543 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.31421 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.22789 | 52 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.57337 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.35476 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.44761 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.24957 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.27292 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.25603 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.2762 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.26505 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.29155 | 53 |